Literature DB >> 34309778

Additional Esophagectomy Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma: is it a Reasonable Strategy?

Masayuki Watanabe1.   

Abstract

Entities:  

Year:  2021        PMID： 34309778     DOI： 10.1245/s10434-021-10513-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  ASO Visual Abstract: Exposure to Blood Components and Inflammation Contribute to Pancreatic Cancer Progression.

Authors:  Ryo Saito; Hiromichi Kawaida; Naohiro Hosomura; Hidetake Amemiya; Jun Itakura; Atsushi Yamamoto; Koichi Takiguchi; Suguru Maruyama; Katsutoshi Shoda; Shinji Furuya; Hidenori Akaike; Yoshihiko Kawaguchi; Makoto Sudo; Shingo Inoue; Hiroshi Kono; Daisuke Ichikawa
Journal:  Ann Surg Oncol       Date:  2021-12       Impact factor: 5.344

2.  ASO Visual Abstract: Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma-A Comparison of Outcomes Between Esophagectomy and Chemoradiotherapy.

Authors:  Yasukazu Kanie; Akihiko Okamura; Takao Asari; Suguru Maruyama; Kei Sakamoto; Daisuke Fujiwara; Jun Kanamori; Yu Imamura; Akiyoshi Ishiyama; Toshiyuki Yoshio; Tomohiro Tsuchida; Keisho Chin; Masayuki Watanabe
Journal:  Ann Surg Oncol       Date:  2021-12       Impact factor: 5.344

3.  Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer.

Authors:  Yoshinori Handa; Yasuhiro Tsutani; Takahiro Mimae; Yoshihiro Miyata; Hiroyuki Ito; Yoshihisa Shimada; Haruhiko Nakayama; Norihiko Ikeda; Morihito Okada
Journal:  Ann Surg Oncol       Date:  2021-07-03       Impact factor: 5.344

4.  ASO Visual Abstract: A Nomogram Based on a Collagen Feature Support Vector Machine for Predicting the Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients.

Authors:  Wei Jiang; Min Li; Jie Tan; Mingyuan Feng; Jixiang Zheng; Dexin Chen; Zhangyuanzhu Liu; Botao Yan; Guangxing Wang; Shuoyu Xu; Weiwei Xiao; Yuanhong Gao; Shuangmu Zhuo; Jun Yan
Journal:  Ann Surg Oncol       Date:  2021-12       Impact factor: 5.344
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.